Search Results - "Shoblock, James R"

Refine Results
  1. 1
  2. 2

    Selective blockade of the orexin-2 receptor attenuates ethanol self-administration, place preference, and reinstatement by Shoblock, James R., Welty, Natalie, Aluisio, Leah, Fraser, Ian, Motley, S. Timothy, Morton, Kirsten, Palmer, James, Bonaventure, Pascal, Carruthers, Nicholas I., Lovenberg, Timothy W., Boggs, Jamin, Galici, Ruggero

    Published in Psychopharmacologia (01-05-2011)
    “…Rationale Orexin-1 receptor antagonists have been shown to block the reinforcing effects of drugs of abuse and food. However, whether blockade of orexin-2…”
    Get full text
    Journal Article
  3. 3

    In vivo Characterization of a Selective, Orally Available, and Brain Penetrant Small Molecule GPR139 Agonist by Shoblock, James R, Welty, Natalie, Fraser, Ian, Wyatt, Ryan, Lord, Brian, Lovenberg, Timothy, Liu, Changlu, Bonaventure, Pascal

    Published in Frontiers in pharmacology (21-03-2019)
    “…Recently, our group along with another demonstrated that GPR139 can be activated by L-phenylalanine (L-Phe) and L-tryptophan (L-Trp) at physiologically…”
    Get full text
    Journal Article
  4. 4
  5. 5

    The effects of thioperamide on extracellular levels of glutamate and GABA in the rat prefrontal cortex by Welty, Natalie, Shoblock, James R.

    Published in Psychopharmacologia (01-12-2009)
    “…Rationale Histamine H3 receptors (H3R) are presynaptic heteroreceptors that negatively modulate the release of histamine and other neurotransmitters such as…”
    Get full text
    Journal Article
  6. 6

    Neurochemical and behavioral differences between d-methamphetamine and d-amphetamine in rats by SHOBLOCK, James R, SULLIVAN, Eric B, MAISONNEUVE, Isabelle M, GLICK, Stanley D

    Published in Psychopharmacologia (01-02-2003)
    “…Methamphetamine (METH) and amphetamine (AMPH) are both abused psychostimulants. Although METH is generally accepted to be more addictive and potent than its…”
    Get full text
    Journal Article
  7. 7

    Constitutively Active Mu Opioid Receptors Mediate the Enhanced Conditioned Aversive Effect of Naloxone in Morphine-Dependent Mice by SHOBLOCK, James R, MAIDMENT, Nigel T

    Published in Neuropsychopharmacology (New York, N.Y.) (01-01-2006)
    “…Naloxone administration produces a robust conditioned place aversion (CPA) in opiate-naive rodents by blocking the action of enkephalins at mu opioid…”
    Get full text
    Journal Article
  8. 8

    Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ‐47965567 by Bhattacharya, Anindya, Wang, Qi, Ao, Hong, Shoblock, James R, Lord, Brian, Aluisio, Leah, Fraser, Ian, Nepomuceno, Diane, Neff, Robert A, Welty, Natalie, Lovenberg, Timothy W, Bonaventure, Pascal, Wickenden, Alan D, Letavic, Michael A

    Published in British journal of pharmacology (01-10-2013)
    “…Background and Purpose An increasing body of evidence suggests that the purinergic receptor P2X, ligand‐gated ion channel, 7 (P2X7) in the CNS may play a key…”
    Get full text
    Journal Article
  9. 9
  10. 10

    The effect of a systemically active ORL-1 agonist, Ro 64-6198, on the acquisition, expression, extinction, and reinstatement of morphine conditioned place preference by Shoblock, James R., Wichmann, Jürgen, Maidment, Nigel T.

    Published in Neuropharmacology (01-09-2005)
    “…ORL-1 agonists have been proposed as potential therapeutics for substance abuse based on their propensity to counter the effects of mu opioid agonists in…”
    Get full text
    Journal Article
  11. 11

    Differences between d-methamphetamine and d-amphetamine in rats: working memory, tolerance, and extinction by SHOBLOCK, James R, MAISONNEUVE, Isabelle M, GLICK, Stanley D

    Published in Psychopharmacologia (01-11-2003)
    “…Previously, we have shown that d-amphetamine (AMPH) was more potent than d-methamphetamine (METH) at increasing extracellular levels of dopamine (DA) in the…”
    Get full text
    Journal Article
  12. 12

    Differential interactions of desipramine with amphetamine and methamphetamine: evidence that amphetamine releases dopamine from noradrenergic neurons in the medial prefrontal cortex by Shoblock, James R, Maisonneuve, Isabelle M, Glick, Stanley D

    Published in Neurochemical research (01-07-2004)
    “…Amphetamine is more effective than methamphetamine at raising dopamine levels in the prefrontal cortex. The current study tested the hypothesis that…”
    Get full text
    Journal Article
  13. 13

    The Pharmacology of Ro 64‐6198, a Systemically Active, Nonpeptide NOP Receptor (Opiate Receptor‐Like 1, ORL‐1) Agonist with Diverse Preclinical Therapeutic Activity by Shoblock, James R.

    Published in CNS drug reviews (01-03-2007)
    “…ABSTRACT The NOP receptor (formerly referred to as opiate receptor‐like 1, ORL‐1, LC132, OP4, or NOP1) is a G protein–coupled receptor that shares high…”
    Get full text
    Journal Article
  14. 14

    PET Brain Imaging of Neuropeptide Y2 Receptors Using N-^sup 11^C-Methyl-JNJ-31020028 in Pigs by Winterdahl, Michael, Audrain, Hélène, Landau, Anne M, Smith, Donald F, Bonaventure, Pascal, Shoblock, James R, Carruthers, Nicholas, Swanson, Devin, Bender, Dirk

    Published in The Journal of nuclear medicine (1978) (01-04-2014)
    “…Neuropeptide Y2 (NPY2) receptors are implicated in diverse brain disorders, but no suitable PET radiotracers are currently available for studying NPY2…”
    Get full text
    Journal Article
  15. 15
  16. 16

    PET Brain Imaging of Neuropeptide Y2 Receptors Using N- sigma up 11 not equal to -Methyl-JNJ-31020028 in Pigs by Winterdahl, Michael, Audrain, Helene, Landau, Anne M, Smith, Donald F, Bonaventure, Pascal, Shoblock, James R, Carruthers, Nicholas, Swanson, Devin, Bender, Dirk

    Published in The Journal of nuclear medicine (1978) (01-04-2014)
    “…Neuropeptide Y2 (NPY2) receptors are implicated in diverse brain disorders, but no suitable PET radiotracers are currently available for studying NPY2…”
    Get full text
    Journal Article
  17. 17

    Constitutively active micro opioid receptors mediate the enhanced conditioned aversive effect of naloxone in morphine-dependent mice by Shoblock, James R, Maidment, Nigel T

    Published in Neuropsychopharmacology (New York, N.Y.) (01-01-2006)
    “…Naloxone administration produces a robust conditioned place aversion (CPA) in opiate-naive rodents by blocking the action of enkephalins at mu opioid…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20